96303 ⎘
Compounds without a metal-carbon linkage
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
#302Catalyst composition
#303Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides
#304Crowned dithiocarbamate metal complexes and methods for their use
#305Conjugated polymer end-capped with phosphorescent organometallic complex, light-emitting element and light-emitting device
#306Pendant fatty acid imaging agents
#307Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
#308Diimine metal complexes, methods of synthesis, and method of using in oligomerization and polymerization
#309Catalysts and methods for catalytic oxidation
#310Imaging agents
#311Polymerisation catalysts
#312Catalyst composition II
#313Photochromic diarylethene-containing coordination compounds and the production thereof
#314Tc-labeled arylpiperazine derivatives for imaging serotonin receptor
#315Compounds that selectively bind to membranes of apoptotic cells
#316Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
#317Boat tropanes
#318Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
#319Use of metal complex compounds as oxidation catalysts
#320Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases
#321Method for treating a mammal by administration of a compound having the ability to release CO
#322Peroxynitrite decomposition catalysts and methods of use thereof
#323Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
#324Metal-complex compound and organic electroluminescence device using the compound
#325Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
#326Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
#327Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
#328Water-soluble anionic bacteriochlorophyll derivatives and their uses
#329Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof
#330Biopolymers modified with superoxide dismutase mimics
#331Compounds for myocardial perfusion imaging
#332Rhenium compounds
#333Methods for preparing metal-carborane complexes for radioimaging and radiotherapy
#334Organometallic anti-tumour agent
#335Amyloid plaque aggregation inhibitors and diagnostic imaging agents
#336Transition metal complexes with proton sponges as ligands
#337Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
#338Pyridyl-substituted porphyrin compounds and methods of use thereof
#339Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
#340Bridged aromatic substituted amine ligands with donor atoms
#341Biphenyls and fluorenes as imaging agents in alzheimer's disease
#342Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
#343Organometallic complex, organic EL element and organic EL display
#344Mitochondrially targeted antioxidants
#345Radiolabeled compounds and liposomes and their method of making and using same
#346Phospholipid analogs as diapeutic* agents and methods thereof
#347Tumor imaging compounds
#348SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease
#349Cycloamide-transition metal complexes and bleach catalysts
#350Polymers having attached luminescent metal complexes and devices made with such polymers
#351Perturbed membrane-binding compounds and methods of using the same
#352P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
#353Reduction of Contaminants In Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light
#354Manganese(IV) complex salts and their use as oxidation catalysts
#355Polypodal chelants for metallopharmaceuticals
#356Photochromic diarylethene-containing coordination compounds and the production thereof
#357Metal catalysts and methods for making and using same
#358Chelants and macrocyclic metal complex radiopharmaceuticals thereof
#359Chelants and macrocyclic metal complex radiopharmaceuticals thereof
#360Technetium or rhenium complexes, radiopharmaceutical products comprising them